DE602004017884D1 - Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren - Google Patents
Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitorenInfo
- Publication number
- DE602004017884D1 DE602004017884D1 DE602004017884T DE602004017884T DE602004017884D1 DE 602004017884 D1 DE602004017884 D1 DE 602004017884D1 DE 602004017884 T DE602004017884 T DE 602004017884T DE 602004017884 T DE602004017884 T DE 602004017884T DE 602004017884 D1 DE602004017884 D1 DE 602004017884D1
- Authority
- DE
- Germany
- Prior art keywords
- protein kinase
- stocks
- fluorescence
- kinase inhibitors
- binding assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B11/00—Diaryl- or thriarylmethane dyes
- C09B11/04—Diaryl- or thriarylmethane dyes derived from triarylmethanes, i.e. central C-atom is substituted by amino, cyano, alkyl
- C09B11/10—Amino derivatives of triarylmethanes
- C09B11/24—Phthaleins containing amino groups ; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B55/00—Azomethine dyes
- C09B55/002—Monoazomethine dyes
- C09B55/003—Monoazomethine dyes with the -C=N- group attached to an heteroring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50853903P | 2003-10-03 | 2003-10-03 | |
PCT/US2004/032253 WO2005033330A2 (en) | 2003-10-03 | 2004-09-30 | Fluorescent probes for use in protein kinase inhibitor binding assay |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004017884D1 true DE602004017884D1 (de) | 2009-01-02 |
Family
ID=34421754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004017884T Active DE602004017884D1 (de) | 2003-10-03 | 2004-09-30 | Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren |
Country Status (8)
Country | Link |
---|---|
US (2) | US7125996B2 (de) |
EP (1) | EP1670789B1 (de) |
JP (1) | JP4949845B2 (de) |
AT (1) | ATE414701T1 (de) |
CA (1) | CA2541059C (de) |
DE (1) | DE602004017884D1 (de) |
ES (1) | ES2315713T3 (de) |
WO (1) | WO2005033330A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1490062B1 (de) * | 2002-03-26 | 2007-12-19 | Boehringer Ingelheim Pharmaceuticals Inc. | Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung |
JP4619786B2 (ja) * | 2002-08-29 | 2011-01-26 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 炎症性、アレルギー性及び増殖性疾患の治療において糖質コルチコイドミメティックスとして使用するための3−(スルホンアミドエチル)−インドール誘導体 |
UY28526A1 (es) * | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos |
US7795272B2 (en) * | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
US7635711B2 (en) * | 2004-12-27 | 2009-12-22 | Boehringer-Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
WO2007057397A1 (en) * | 2005-11-15 | 2007-05-24 | Boehringer Ingelheim International Gmbh | Treatment of cancer |
EE200600030A (et) * | 2006-08-15 | 2008-04-15 | Tartu �likool | Proteiinkinaasi fluorestsents-sond |
KR20090097908A (ko) * | 2006-12-06 | 2009-09-16 | 베링거 인겔하임 인터내셔날 게엠베하 | 글루코코르티코이드 모사물, 이의 제조 방법, 이의 약제학적 조성물 및 용도 |
WO2009097318A1 (en) * | 2008-01-28 | 2009-08-06 | Bristol-Myers Squibb Company | A fluorescence polarization binding assay for characterizing glucokinase ligands |
EP2300472B1 (de) * | 2008-06-06 | 2012-01-18 | Boehringer Ingelheim International GmbH | Glucocorticoidmimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und anwendungen davon |
WO2010149190A1 (en) * | 2009-06-26 | 2010-12-29 | Max-Planck-Gesellschaft Zur | Novel fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques |
EP2482072B1 (de) | 2011-01-26 | 2016-07-06 | University of Tartu | Photolumineszierenden sonde |
EP2700946A1 (de) * | 2012-08-24 | 2014-02-26 | University of Tartu | Bisubstratfluoreszente Sonden für Proteinkinase CK2 |
CN114292281B (zh) * | 2021-12-22 | 2023-10-24 | 东南大学 | 一种用于实现细胞内脂滴动态成像的小分子荧光探针及其制备方法和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06172312A (ja) * | 1992-03-04 | 1994-06-21 | Wako Pure Chem Ind Ltd | 1級アミノ基を有する化合物の蛍光標識化方法 |
JP3851706B2 (ja) * | 1996-05-20 | 2006-11-29 | 日清紡績株式会社 | 蛍光性基含有カルボジイミド化合物 |
DE19816624A1 (de) * | 1998-04-15 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
US6169106B1 (en) | 1998-04-15 | 2001-01-02 | Boehringer Ingelheim Pharma Kg | Indolinones having kinase inhibitory activity |
CN1319090A (zh) * | 1998-09-25 | 2001-10-24 | 贝林格尔英格海姆法玛公司 | 新的取代的二氢吲哚酮、它们的制备方法和它们作为药物的用途 |
WO2003012046A2 (en) * | 2001-07-27 | 2003-02-13 | The Regents Of The University Of California | Stk15 (stk6) gene polymorphism and methods of determining cancer risk |
GB0124299D0 (en) * | 2001-10-10 | 2001-11-28 | Astrazeneca Ab | Crystal structure of enzyme and uses thereof |
CA2463989C (en) * | 2001-10-17 | 2012-01-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof |
ATE440087T1 (de) * | 2003-01-30 | 2009-09-15 | Boehringer Ingelheim Pharma | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen |
-
2004
- 2004-09-30 DE DE602004017884T patent/DE602004017884D1/de active Active
- 2004-09-30 AT AT04789404T patent/ATE414701T1/de active
- 2004-09-30 ES ES04789404T patent/ES2315713T3/es active Active
- 2004-09-30 WO PCT/US2004/032253 patent/WO2005033330A2/en active Application Filing
- 2004-09-30 JP JP2006534117A patent/JP4949845B2/ja active Active
- 2004-09-30 US US10/955,129 patent/US7125996B2/en active Active
- 2004-09-30 EP EP04789404A patent/EP1670789B1/de active Active
- 2004-09-30 CA CA2541059A patent/CA2541059C/en active Active
-
2006
- 2006-07-25 US US11/492,654 patent/US7588899B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20050100978A1 (en) | 2005-05-12 |
JP2007509845A (ja) | 2007-04-19 |
CA2541059C (en) | 2013-09-17 |
US7588899B2 (en) | 2009-09-15 |
US20060263841A1 (en) | 2006-11-23 |
JP4949845B2 (ja) | 2012-06-13 |
EP1670789B1 (de) | 2008-11-19 |
WO2005033330A3 (en) | 2005-07-28 |
CA2541059A1 (en) | 2005-04-14 |
WO2005033330A2 (en) | 2005-04-14 |
ATE414701T1 (de) | 2008-12-15 |
EP1670789A2 (de) | 2006-06-21 |
ES2315713T3 (es) | 2009-04-01 |
US7125996B2 (en) | 2006-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004017884D1 (de) | Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren | |
ATE480643T1 (de) | Homogener nachweis von analyten | |
UA93989C2 (ru) | Способ прогнозирования otbeta ha лечение | |
NO20074389L (no) | Bestemmelse av respondere til kjemoterapi | |
DE60215626D1 (de) | Antagonist für die multimerisierung von hiv-1 vif-protein | |
ATE540114T1 (de) | Verfahren und zusammensetzungen zur schnellen isolierung kleiner rna-moleküle | |
ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
ATE395336T1 (de) | Chinolinderivate zur verwendung als inhibitoren von mycobakterien | |
ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
CY1115640T1 (el) | Διαγνωση και αγωγη εναντι της σχιζοφρενειας | |
ATE365319T1 (de) | Methode zur identifizierung von regulatoren der bildung von protein-age-derivaten | |
ATE495243T1 (de) | Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung | |
ATE404692T1 (de) | Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen. | |
ATE345397T1 (de) | Verfahren zur isolierung von bakterien aus biologischen proben | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
ATE487141T1 (de) | Hemmung von gasc1 | |
DE602004011228D1 (de) | Verfahren und zusammensetzungen zur bestimmung glycierter proteine | |
DE60221550D1 (de) | Methode zur bestimmung der zellzyklusposition | |
DE60025336D1 (de) | Verfahren und kit zur früherkennung von krebs | |
ATE503999T1 (de) | Stabiles, chromogenes testreagenz und dessen verwendung in gerinnungsdiagnostischen tests | |
ATE500505T1 (de) | Enzymhemmungsimmunverfahren | |
WO2007127002A3 (en) | Protein markers of responsiveness to type iii receptor tyrosine kinase inhibitors | |
ATE447610T1 (de) | Kristalliner vap-1 und verwendung | |
ATE430317T1 (de) | Enzymatische messung von imatinib-mesylat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |